CEO
Stanislas Veillet
Employees
14
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
biophytis is a biotech company developping therapeutics for aging diseases. it that has been created in 2006 as a spin-off of université pierre et marie curie (paris). biophytis has developped a portfolio of drug candidates at clinical stage for the treatment of sarcopenic obesity (bio101, bio103) and dry age-related macular degeneration (bio201).
Loading...
Open
8.24
Mkt cap
2.6M
Volume
18K
High
8.96
P/E Ratio
-0.06
52-wk high
168.80
Low
8.05
Div yield
N/A
52-wk low
8.05
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.